Considering efficacy and cost, where does ramucirumab fit in the management of metastatic colorectal cancer?

Dandaniel A. Goldstein*, Bassel F. El-Rayes

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations
Original languageEnglish
Pages (from-to)981-982
Number of pages2
JournalOncologist
Volume20
Issue number9
DOIs
StatePublished - 11 Aug 2015
Externally publishedYes

Cite this